Who owns AIM IMMUNOTECH INC?
- Ticker: AIM
- CUSIP Number: 00901b303
Tip: Access positions for across all investors
Analyze quarterly positions in Aim Immunotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aim Immunotech stock
Who bought or sold AIM IMMUNOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DRW Holdings | 70k | $79k | 61% | Dec 2025 |
|
| Vanguard Group | 18k | $20k | 0% | Dec 2025 |
|
| Geode Capital Management | 17k | $20k | 7% | Dec 2025 |
|
| UBS Group | 379.00 | $428.004700 | 25% | Dec 2025 |
|
| Community Bank | 132.00 | $146.995200 | 0% | Dec 2025 |
|
| Tower Research Capital | 125.00 | $141.000000 | 100% | Dec 2025 |
|
| Advisor Group Holdings | 15.00 | $16.000500 | 0% | Dec 2025 |
|
| Hoey Investments | 10.00 | $12.000000 | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 2.00 | $2.000000 | 0% | Dec 2025 |
|
| Farther Finance Advisors | 1.00 | $1.000000 | 0% | Dec 2025 |
|
Who sold out of Aim Immunotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sabby Management | Sep 2025 | 29k | $79k |
| Pnc Financial Services | Sep 2025 | 50.00 | $137.000000 |
| Harbour Investments | Sep 2025 | 10.00 | $27.000000 |
| Wells Fargo & Company | Sep 2025 | 4.00 | $11.000000 |